Here are tax-savvy ways to donate money, according to a charitable giving expert
If you're planning to donate money, certain charitable giving moves provide a bigger tax benefit. Here's what investors need to know.
Millionaires see market volatility, inflation among biggest threats to wealth, CNBC survey finds
CNBC's latest millionaire survey reveals the biggest threats to personal wealth. Here are the best ways to protect from these risks, according to experts.
Metals Stocks: Gold drifts lower as traders gauge Fed’s rate path
Gold futures edged lower early Wednesday, remaining stuck in a range as investors await further clues on the Federal Reserve's interest rate path.
The Ratings Game: Netflix stock rises toward 16-month high as analyst praises path to make more money on ‘borrowers’
Netflix's stock jumped toward a 16-month high Wednesday, after J.P. Morgan boosted its price target by 24% on increased optimism over the paid-sharing rollout.
: Ollie’s stock rises on boosted adj. profit view
Ollie’s Bargain Outlet Holdings Inc. OLLI stock is up 3% in premarket trades Wednesday after the closeout merchandise retailer boosted its fiscal 2024 outlook for...
: FibroGen shares slide after Duchenne muscular dystrophy treatment falls short in trial
Shares of FibroGen Inc. FGEN were down 5.6% premarket on Wednesday after the company announced disappointing results from a late-stage trial of pamrevlumab in non-ambulatory...
: Apollo lines up warehouse financing commitment from Abu Dhabi Investment Authority
Apollo Global Management Inc. APO said Wednesday it received a commitment from Abu Dhabi Investment Authority (ADIA) for warehouse financing deals by its new asset-backed...
: Jack Daniel’s parent Brown-Forman stock gains after sales top expectations, amid strength in premium bourbons and RTDs
Shares of Jack Daniel’s-parent Brown-Forman Corp. BF.B edged up 0.3% in premarket trading Wednesday, after the spirits company reported fiscal fourth-quarter profit that matched expectations...
: Coya Therapeutics stock gains on new data from Alzheimer’s study
Shares of Coya Therapeutics Inc. COYA gained 12% premarket on Wednesday after the clinical-stage biotech company released new data from a study of its investigational...